CaseTrail

Rutledge v. Pharmaceutical Care Management Association

141 S. Ct. 474 · Decided December 10, 2020 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

Rutledge v. Pharmaceutical Care Management Association was decided on December 10, 2020 unanimously (8–0). The Court reversed the lower court's decision and remanded the case. Justice Sonia Sotomayor wrote the opinion of the Court. SCDB classifies its main issue as “Federal preemption of state legislation or regulation” in the Federalism area.

Read the opinion

Case details

Citations
141 S. Ct. 474 · 208 L. Ed. 2d 327 · 2020 U.S. LEXIS 5988
Docket number
18-540
Decided
December 10, 2020
Argued
October 6, 2020
Court era
Roberts Court
Decision type
Opinion of the Court (orally argued)
Disposition
Reversed and remanded
Outcome for petitioner
The petitioning party received a favorable disposition
Vote
8–0 (unanimous)
Majority opinion
Sonia Sotomayor
Opinion assigned by
John G. Roberts Jr.
How the case arrived
Certiorari
Issue area
Federalism
Legal provision
Employee Retirement Income Security Act (ERISA)
Type of law
Federal statute
Decision direction (SCDB)
Liberal what this means

How the Justices voted

Did not participate: Amy Coney Barrett.

Full case caption

Rutledge v. Pharmaceutical Care Management Association

SCDB identifiers: case 2020-004, docket 2020-004-01.

Other cases on “Federal preemption of state legislation or regulation”

See all

Cases on the same legal provision: Employee Retirement Income Security Act (ERISA)

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error